Atlas Trials

Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer

Clinical trial NCT00237575 · TERMINATED

Trial details

NCT number
NCT00237575
Sponsor
University of Kentucky
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2005-11-01
Primary completion
2006-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.